Treatment Overview
The High-Risk Glaucoma Surveillance Program in Korea is an intensive monitoring and management system specifically designed for patients with elevated risk of developing glaucoma or progressing rapidly. This program uses advanced imaging, AI-driven trend analysis, and short-interval follow-ups to detect early structural or functional changes before vision loss occurs.
Korean glaucoma centers are leaders in high-risk surveillance due to their integration of:
- High-frequency OCT and RNFL/GCC monitoring
- OCTA-based optic nerve microvascular evaluation
- 24-hour and diurnal IOP fluctuation assessments
- AI-supported progression prediction
- Deep-angle and drainage system imaging (AS-OCT, UBM)
- Digital tracking for IOP, symptoms, and treatment response
This proactive surveillance approach prevents late diagnosis and helps preserve vision in populations most vulnerable to rapid deterioration.
Purpose & Benefits
Purpose
- Identify early glaucoma changes in high-risk individuals
- Detect disease progression sooner than standard monitoring
- Closely monitor IOP, optic nerve structure, and visual function
- Provide targeted interventions before significant vision loss
- Establish individualized treatment timelines
- Guide appropriate therapy escalation such as SLT or MIGS
Benefits
- Significantly earlier detection of optic nerve damage
- Reduced risk of rapid or silent progression
- Personalized surveillance intervals based on risk category
- Comprehensive imaging for maximum accuracy
- Enhanced prevention of irreversible visual field loss
- AI-enhanced prediction of future risk
- Integrated monitoring across structure, function, and IOP
Ideal Candidates
The High-Risk Glaucoma Surveillance Program in Korea is ideal for:
- Individuals with strong family history of glaucoma
- Patients with extremely thin corneas or large optic nerve cups
- Those with high myopia or hyperopia
- Individuals with elevated or fluctuating IOP
- Patients with normal-tension glaucoma (NTG)
- People with vascular conditions (migraine, vasospasm, sleep apnea)
- Patients with diabetes or hypertension
- Individuals with early imaging abnormalities but no clear visual field loss
Possible Risks & Complications
The surveillance program is safe and non-invasive. However, underlying high-risk conditions may involve:
- Higher susceptibility to optic nerve thinning
- Risk of missed fluctuations without close follow-up
- Medication intolerance requiring frequent adjustments
- Anxiety related to frequent monitoring
Korean clinics mitigate these issues with:
- AI-supported trend correction
- Repeated imaging when needed
- Detailed patient counseling
- Personalized follow-up schedules (every 1–3 months)
Surgical Techniques
(These may be recommended if surveillance data shows deterioration.)
1. Selective Laser Trabeculoplasty (SLT)
Used as early intervention to stabilize IOP in high-risk patients.
2. MicroPulse Laser Therapy
Effective for NTG and vascular-related optic nerve stress.
3. MIGS (Minimally Invasive Glaucoma Surgery)
Chosen when imaging confirms early structural progression despite treatment:
- iStent Inject
- Hydrus Microstent
- KDB Goniotomy
- Canaloplasty
- GATT
4. Filtration Surgeries
For patients with severe or fast progression:
- Trabeculectomy
- PreserFlo MicroShunt
- Tube shunts (Ahmed, Baerveldt)
5. Tailored Medication Intensification
Adjusted based on diurnal peaks and AI-predicted progression speed.
Treatment Process in Korea
Step 1 – High-Risk Classification & Baseline Imaging
Detailed evaluation of optic nerve structure, corneal thickness, IOP patterns, and vascular status.
Step 2 – Multi-Modal Diagnostic Testing
Includes OCT, OCTA, visual field tests, and anterior segment imaging.
Step 3 – AI-Based Risk & Progression Analysis
Algorithm calculates predicted progression rate and vulnerability.
Step 4 – Customized Surveillance Schedule
Follow-ups every 1–3 months depending on risk category.
Step 5 – Treatment Adjustment & Intervention
Laser, MIGS, or medication escalation based on early detection.
Program Duration: Ongoing
Setting: Outpatient glaucoma surveillance center
Recovery & After-Care
After-Care Guidelines
- Maintain all scheduled follow-up visits
- Report changes such as dimming, halos, or pressure pain
- Follow medication and lifestyle recommendations
- Use digital tracking tools to log IOP or symptoms
- Monitor systemic health (blood pressure, sleep quality)
- After laser/MIGS, follow post-procedure instructions carefully
Recovery Timeline
Immediately: Resume normal activities after diagnostic tests
Weeks 1–4: Treatment adjustments begin to stabilize optic nerve function
3–6 Months: Trend stability becomes measurable
6–12 Months: Long-term risk level reassessed
Results & Longevity
Expected Results
- Early detection of rapid progression
- stabilized IOP and optic nerve health
- Reduced risk of sudden field loss
- Highly targeted intervention timing
- Improved long-term visual outcomes
- Greater safety for individuals with genetic or anatomical risks
Longevity
- High-risk individuals benefit from lifelong monitoring
- AI-powered trend analysis becomes more accurate with long-term data
- Early intervention prevents severe stages
- Consistent surveillance preserves eyesight over decades
Why Korea Is a Top Destination
- World-class glaucoma imaging and monitoring systems
- AI-driven prediction tools for high-risk patients
- Highly experienced specialists in NTG and genetic glaucoma
- Frequent follow-up capabilities with advanced diagnostics
- Laser-first and MIGS-first approaches for safe early care
- Exceptional long-term visual protection outcomes
Unique Korean Innovations
- AI-based high-risk scoring algorithms
- Multi-layered structural + vascular progression modeling
- Smart follow-up scheduling systems
- Subclinical RNFL and GCC thinning detection
- Nocturnal IOP fluctuation analysis
- Predictive optic nerve vulnerability mapping
These innovations make Korea’s High-Risk Glaucoma Surveillance Program one of the most advanced systems for protecting high-risk individuals from disease progression.
Cost Range (Indicative Estimate)
| Program Package | Price (KRW) | Approx. USD | Inclusions |
|---|---|---|---|
| Basic High-Risk Screening Package | ₩150,000 – ₩300,000 | ~$110 – $230 | OCT + IOP + angle assessment |
| Advanced High-Risk Surveillance Program | ₩400,000 – ₩900,000 | ~$300 – $680 | OCTA + VF + AI progression scoring |
| Comprehensive High-Risk Management Plan | ₩1,200,000 – ₩2,500,000+ | ~$900 – $1,900+ | Full imaging + frequent follow-up + treatment planning |
Popular Clinics in Korea
- B&VIIT Eye Center (Seoul)
- Dream Eye Center (Seoul)
- BGN Eye Clinic (Seoul & Busan)
- Glory Seoul Eye Clinic
- K-Cure Vision Center (Gangnam)
